BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 13346452)

  • 1. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation.
    FORWELL GD; INGRAM GI
    J Pharm Pharmacol; 1956 Jul; 8(7):530-45. PubMed ID: 13346452
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate.
    HJORT P; STORMORKEN H; GILJE O
    Scand J Clin Lab Invest; 1957; 9 Suppl 29():1-86. PubMed ID: 13506569
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro comparative assays of the anticoagulant activity of dextran sulphate and heparin.
    GRASSET E; SCHWARTZ DE
    Br J Pharmacol Chemother; 1955 Sep; 10(3):317-20. PubMed ID: 13269707
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin.
    BORCHGREVINK CF
    Acta Med Scand; 1961 Sep; 170():365-73. PubMed ID: 13871206
    [No Abstract]   [Full Text] [Related]  

  • 7. Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
    COHEN H; TUDHOPE GR
    Br Med J; 1956 Nov; 2(5000):1023-7. PubMed ID: 13364378
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
    Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiments with dextran sulphate as an anticoagulant.
    WALTON K
    Proc R Soc Med; 1951 Jul; 44(7):563-4. PubMed ID: 14864548
    [No Abstract]   [Full Text] [Related]  

  • 10. The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.
    Silverberg M; Diehl SV
    Biochem J; 1987 Dec; 248(3):715-20. PubMed ID: 2449171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of heparin, dextran sulphate, and 5-hydroxytryptamine.
    LAMBERT HP
    Clin Sci; 1958 Nov; 17(4):621-8. PubMed ID: 13608972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of dextran sulphate on blood coagulation].
    Hiramaru M
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):652-61. PubMed ID: 5535819
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E
    Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
    [No Abstract]   [Full Text] [Related]  

  • 15. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticoagulant activity of dextran sulphate. II. The effect of dextran sulphate on the one-stage prothrombin time.
    INGRAM GI; FORWELL GD
    J Pharm Pharmacol; 1956 Aug; 8(8):589-601. PubMed ID: 13346455
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic trial of the synthetic heparin analogue dextran sulphate.
    RICKETTS CR; WALTON KW; VAN LEUVEN BD; BIRBECK A; BROWN A; KENNEDY AC; BURT CC
    Lancet; 1953 Nov; 265(6794):1004-10. PubMed ID: 13110037
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic toxicity of dextran sulphate in rabbits.
    HINT HC; RICHTER AW
    Br J Pharmacol Chemother; 1958 Jun; 13(2):109-12. PubMed ID: 13536272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of factor VIII-associated platelet aggregation by heparin and dextran sulfate, and its mechanism.
    Suzuki K; Nishioka J; Hashimoto S
    Biochim Biophys Acta; 1979 Jul; 585(3):416-26. PubMed ID: 486540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.